logo    Company Page

Most Recent Insiders Activity

Transaction Date Company Name Insider Name (Title) Activity Stock Acquired or Disposed Shares Price range Amount
2024-10-08 ALNYLAM PHARMACEUTICALS, INC. Garg Pushkal
(CMO & EVP Dev & Med Affairs)
A Common Stock A 96 $0.00 - $0.00 $0
2024-08-20 ALNYLAM PHARMACEUTICALS, INC. Greenstreet Yvonne
(Chief Executive Officer)
S Common Stock D 15000 $280.00 - $280.00 $4,200,000
2024-08-20 ALNYLAM PHARMACEUTICALS, INC. Greenstreet Yvonne
(Chief Executive Officer)
M Common Stock A 15000 $85.00 - $85.00 $1,275,000
2024-08-01 ALNYLAM PHARMACEUTICALS, INC. Greenstreet Yvonne
(Chief Executive Officer)
S Common Stock D 15148 $270.00 - $270.00 $4,089,960
2024-08-01 ALNYLAM PHARMACEUTICALS, INC. Greenstreet Yvonne
(Chief Executive Officer)
M Common Stock A 15148 $85.00 - $85.00 $1,287,580
2024-07-11 ALNYLAM PHARMACEUTICALS, INC. Greenstreet Yvonne
(Chief Executive Officer)
S Common Stock D 7093 $261.00 - $261.00 $1,851,273
2024-06-24 ALNYLAM PHARMACEUTICALS, INC. PYOTT DAVID E I
(Director)
S Common Stock D 32450 $220.00 - $222.00 $7,161,360
2024-06-24 ALNYLAM PHARMACEUTICALS, INC. PYOTT DAVID E I
(Director)
M Common Stock A 32450 $70.20 - $88.95 $2,620,611
2024-06-25 ALNYLAM PHARMACEUTICALS, INC. Garg Pushkal
(CMO & EVP Dev & Med Affairs)
S Common Stock D 2103 $221.71 - $235.19 $485,767
2024-06-24 ALNYLAM PHARMACEUTICALS, INC. Garg Pushkal
(CMO & EVP Dev & Med Affairs)
A Common Stock A 4295 $0.00 - $0.00 $0
2024-06-25 ALNYLAM PHARMACEUTICALS, INC. Greenstreet Yvonne
(Chief Executive Officer)
S Common Stock D 8301 $221.71 - $235.19 $1,917,469
2024-06-24 ALNYLAM PHARMACEUTICALS, INC. Greenstreet Yvonne
(Chief Executive Officer)
A Common Stock A 16953 $0.00 - $0.00 $0
2024-06-25 ALNYLAM PHARMACEUTICALS, INC. Poulton Jeffrey V.
(EVP, Chief Financial Officer)
S Common Stock D 1605 $221.71 - $235.19 $370,739
2024-06-24 ALNYLAM PHARMACEUTICALS, INC. Poulton Jeffrey V.
(EVP, Chief Financial Officer)
A Common Stock A 3278 $0.00 - $0.00 $0
2024-06-25 ALNYLAM PHARMACEUTICALS, INC. Tanguler Tolga
(EVP, Chief Commercial Officer)
S Common Stock D 1605 $221.71 - $235.19 $370,739
2024-06-24 ALNYLAM PHARMACEUTICALS, INC. Tanguler Tolga
(EVP, Chief Commercial Officer)
A Common Stock A 3278 $0.00 - $0.00 $0
2024-06-25 ALNYLAM PHARMACEUTICALS, INC. Fitzgerald Kevin ...
(CSO & EVP, Head of Research)
S Common Stock D 1198 $221.71 - $235.19 $276,724
2024-06-24 ALNYLAM PHARMACEUTICALS, INC. Fitzgerald Kevin ...
(CSO & EVP, Head of Research)
A Common Stock A 2498 $0.00 - $0.00 $0
2024-05-29 ALNYLAM PHARMACEUTICALS, INC. SCHULMAN AMY W
(Director)
S Common Stock D 21700 $148.21 - $149.76 $3,224,544
2024-05-29 ALNYLAM PHARMACEUTICALS, INC. SCHULMAN AMY W
(Director)
M Common Stock A 30000 $66.83 - $66.83 $2,004,900
logo   

Please upgrade to premium to see all results. Signup if you don't have an account.

Login Signup
Activity types
A Grant, award or other acquisition
C Conversion of Derivative or Security
D Disposition to the issuer of issuer equity securities
E Expiration of short derivative position
F Payment of exercise price or tax liability
G Bona fide Gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary Transaction
J Other acquisition or disposition
K Transaction in equity swap or instrument with similar characteristics
L Small Acquisition
M Exercise or conversion of derivative security
O Exercise of out-of-the-money derivative security
P Open Market Purchase
S Open Market Sale
U Disposition pursuant to a tender of shares in a change of control transaction
V Transaction Voluntarily Reported
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust
Debug Info- Version: 2.6